BERTILIMUMAB
UNII 60879E4NED

Substance Identification & Data

This profile provides standardized clinical and technical data for Bertilimumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 60879E4NED.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 375348-49-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
60879E4NED
CAS Registry Number
375348-49-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BERTILIMUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
8332
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bertilimumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BERTILIMUMAB

Common Names & Synonyms

BERTILIMUMAB [INN]
BERTILIMUMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G4, ANTI-(HUMAN EOTAXIN 1) (HUMAN MONOCLONAL CAT-213 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL CAT-213 .KAPPA.-CHAIN, DIMER

Technical Codes

CAT-213
ICO-008